Short answer
Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved potential share issuance exceeding 20% of pre-closing shares under the August 20, 2026 Purchase Agreement.
Gossamer Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders approved potential share issuance exceeding 20% of pre-closing shares under the August 20, 2026 Purchase Agreement
- Approval covers Pre-Funded Warrants, FDA Approval Warrants, and Series A-1, A-2, and A-3 Preferred Stock conversions
- Vote: 2,808,000 for, 37,814 against, and 29,441 abstentions
- Authorization includes issuances to certain executive officers and directors, creating potential dilution and related-party considerations
- Adjournment proposal was not needed after approval
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gossamer Bio, Inc. 8-K filings
Get the next GOSS 8-K as it lands
Follow GOSS for push alerts, or ask the research agent what this filing means.